![Christoph Bausch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: - $ am 31.05.2026
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is Chief Operating Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2017.
Dr. Bausch completed undergraduate studies at the University of Nebraska, earned an MBA from St. Louis University, and obtained a doctorate from The Ohio State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Geschäftsführer | 01.05.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
